This data is for informational purposes only. It is not medical advice. Always consult your transplant team for decisions about your care.

2026 data Public-data reference. official source

Rochester Methodist Hospital (Mayo Clinic)

Open-data reference.

Lung Transplant · Minnesota

Data Insight

Rochester Methodist Hospital (Mayo Clinic)'s lung transplant program is one of 65 lung programs tracked by the Scientific Registry of Transplant Recipients (SRTR) in the November 2025 Program-Specific Report cohort. The center is located in Minnesota and reports under SRTR center code MNMC. These program-level statistics are risk-adjusted for recipient and donor characteristics, which means survival estimates account for factors such as age, diagnosis, and prior medical history rather than comparing raw outcomes.

For the current cohort, this program reports a 1-year graft survival rate of 89.2% and a 3-year rate of 77.6%, compared with a national risk-adjusted benchmark of 89.6% at 1 year. The program performed approximately 102 lung transplants during the reporting window. An estimated 15 candidates sit on this program's waiting list, though time-to-transplant depends heavily on OPTN allocation rules for lung, blood type, medical urgency, and geography.

Among the 65 lung transplant programs reporting to SRTR for this cohort, Rochester Methodist Hospital (Mayo Clinic) ranks #36 by 1-year graft survival, placing the center 0.4 percentage points below the national benchmark. SRTR releases updated Program-Specific Reports approximately twice yearly (typically May and November), and each release incorporates a rolling cohort that may lag by 6-18 months because survival outcomes require follow-up. This page reflects the November 2025 release and is not medical advice — discuss these figures with a qualified transplant team in the context of your individual health status.

89.2%
1-Year Survival
-0.4% vs national
77.6%
3-Year Survival
102
Transplants/yr
15
On Waitlist

National Ranking

By 1-year graft survival rate: #36 of 65 reporting centers

Center 1-yr: 89.2%
National avg 1-yr: 89.6%
Center 3-yr: 77.6%
National avg 3-yr: 72.7%

Other Lung Programs

Top-ranked peer programs by 1-year graft survival rate.

Frequently Asked Questions

What is the lung transplant survival rate at Rochester Methodist Hospital (Mayo Clinic)?

According to SRTR data from November 2025, Rochester Methodist Hospital (Mayo Clinic) reports a 1-year graft survival rate of 89.2% for lung transplants, compared to a national average of 89.6%. The 3-year survival rate is 77.6%. Survival rates are risk-adjusted estimates and may not predict individual outcomes.

How many lung transplants does Rochester Methodist Hospital (Mayo Clinic) perform?

Rochester Methodist Hospital (Mayo Clinic) performed approximately 102 lung transplants during the most recent SRTR reporting period. Higher transplant volume is often associated with greater center experience, though volume alone does not determine outcomes. The OPTN recommends considering multiple factors when evaluating a transplant center.

How long is the lung transplant waiting list at Rochester Methodist Hospital (Mayo Clinic)?

According to the latest SRTR data, approximately 15 patients are on the lung transplant waiting list at Rochester Methodist Hospital (Mayo Clinic). Wait times depend on factors including blood type, medical urgency, body size, geographic region, and organ allocation policies set by OPTN/UNOS. Your transplant team can provide a personalized estimate.

How does Rochester Methodist Hospital (Mayo Clinic) rank nationally for lung transplants?

Rochester Methodist Hospital (Mayo Clinic) ranks #36 out of 65 reporting lung transplant centers nationally by 1-year graft survival rate. The center's rate is 0.4 percentage points below the national average. Rankings are based on SRTR risk-adjusted estimates and exclude centers with insufficient case volume for statistical reliability.

What should I consider before choosing Rochester Methodist Hospital (Mayo Clinic) for a lung transplant?

Beyond survival statistics, important factors include the center's experience with lung transplants, geographic proximity (which affects organ allocation timing through OPTN distribution policies), your insurance network, the multidisciplinary team's expertise, post-transplant follow-up logistics, and the availability of living donor programs if applicable. Discuss all options with your referring physician and the transplant team at Rochester Methodist Hospital (Mayo Clinic).

Data Sources

  • SRTR Program-Specific Reports (November 2025 release) — program-level survival rates, transplant volume, and waitlist size for Rochester Methodist Hospital (Mayo Clinic). srtr.org
  • OPTN lung allocation policy — organ-specific allocation rules referenced in this page's narrative. optn.transplant.hrsa.gov

About This Data

This data is for informational purposes only. It is not medical advice. Always consult your transplant team for decisions about your care.

Source: SRTR Program-Specific Reports, November 2025 SRTR Program-Specific Reports, November 2025 Rankings exclude centers with insufficient case volume for statistical reporting